|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sun J, Song Y, Chen X, Zhao J, Gao P,
Huang X, Xu H and Wang Z: Novel long non-coding RNA RP11-119F7.4 as
a potential biomarker for the development and progression of
gastric cancer. Oncol Lett. 10:115–120. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hauptman N and Glavač D: Long non-coding
RNA in cancer. Int J Mol Sci. 14:4655–4669. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Vance KW, Sansom SN, Lee S, Chalei V, Kong
L, Cooper SE, Oliver PL and Ponting CP: The long non-coding RNA
Paupar regulates the expression of both local and distal genes.
EMBO J. 33:296–311. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wapinski O and Chang HY: Long noncoding
RNAs and human disease. Trends Cell Biol. 21:354–361. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Qi P, Xu MD, Ni SJ, Huang D, Wei P, Tan C,
Zhou XY and Du X: Low expression of LOC285194 is associated with
poor prognosis in colorectal cancer. J Transl Med. 11:1222013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mei D, Song H, Wang K, Lou Y, Sun W, Liu
Z, Ding X and Guo J: Up-regulation of SUMO1 pseudogene 3 (SUMO1P3)
in gastric cancer and its clinical association. Med Oncol.
30:7092013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Song B, Guan Z, Liu F, Sun D, Wang K and
Qu H: Long non-coding RNA HOTAIR promotes HLA-G expression via
inhibiting miR-152 in gastric cancer cells. Biochem Biophys Res
Commun. 464:807–813. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhuang M, Gao W, Xu J, Wang P and Shu Y:
The long non-coding RNA H19-derived miR-675 modulates human gastric
cancer cell proliferation by targeting tumor suppressor RUNX1.
Biochem Biophys Res Commun. 448:315–322. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Arita T, Ichikawa D, Konishi H, Komatsu S,
Shiozaki A, Shoda K, Kawaguchi T, Hirajima S, Nagata H, Kubota T,
et al: Circulating long non-coding RNAs in plasma of patients with
gastric cancer. Anticancer Res. 33:3185–3193. 2013.PubMed/NCBI
|
|
11
|
Fang XY, Pan HF, Leng RX and Ye DQ: Long
noncoding RNAs: Novel insights into gastric cancer. Cancer Lett.
356:357–366. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang E, Li W, Yin D, De W, Zhu L, Sun S
and Han L: c-Myc-regulated long non-coding RNA H19 indicates a poor
prognosis and affects cell proliferation in non-small-cell lung
cancer. Tumor Biol. 37:4007–4015. 2016. View Article : Google Scholar
|
|
13
|
Kim HL, Puymon MR, Qin M, et al: NCCN
Clinical Practice Guidelines in Oncology. 2013.PubMed/NCBI
|
|
14
|
Bosman FT, Carneiro F, Hruban RH and
Theise ND: WHO classification of tumours of the digestive system.
Fourth Edition. World Health Organization. 3:4172010.
|
|
15
|
Washington K: 7th edition of the AJCC
cancer staging manual: Stomach. Ann Surg Oncol. 17:3077–3079. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xia CS, Fan CH and Yang TS: Establishing
reference intervals for serum alpha-fetoprotein and
carcinoembryonic antigen in the normal population. Chin J Lab
Diagnos. 448:31–35. 2013.(In Chinese).
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Resende C, Thiel A, Machado JC and
Ristimäki A: Gastric cancer: Basic aspects. Helicobacter. 16 Suppl
1:S38–S44. 2011. View Article : Google Scholar
|
|
19
|
Timms JF, Arslan-Low E, Kabir M,
Worthington J, Camuzeaux S, Sinclair J, Szaub J, Afrough B, Podust
VN, Fourkala EO, et al: Discovery of serum biomarkers of ovarian
cancer using complementary proteomic profiling strategies.
Proteomics Clin Appl. 8:982–993. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bagaria B, Sood S, Sharma R and Lalwani S:
Comparative study of CEA and CA19-9 in esophageal, gastric and
colon cancers individually and in combination (ROC curve analysis).
Cancer Biol Med. 10:148–157. 2013.PubMed/NCBI
|
|
21
|
Chen W, Zheng R, Zeng H, Zhang S and He J:
Annual report on status of cancer in China, 2011. Chin J Cancer
Res. 27:2–12. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Arita T, Ichikawa D, Konishi H, Komatsu S,
Shiozaki A, Shoda K, Kawaguchi T, Hirajima S, Nagata H, Kubota T,
et al: Circulating long non-coding RNAs in plasma of patients with
gastric cancer. Anticancer Res. 33:3185–3193. 2013.PubMed/NCBI
|
|
23
|
Liu X, Chen Z, Zhao X, Huang M, Wang C,
Peng W, Yin J, Li J, He G, Li X and Zhu X: Effects of IGF2BP2,
KCNQ1 and GCKR polymorphisms on clinical outcome in metastatic
gastric cancer treated with EOF regimen. Pharmacogenomics.
16:959–970. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shimada H, Noie T, Ohashi M, Oba K and
Takahashi Y: Clinical significance of serum tumor markers for
gastric cancer: A systematic review of literature by the Task Force
of the Japanese Gastric Cancer Association. Gastric Cancer.
17:26–33. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Askarian-Amiri ME, Crawford J, French JD,
Smart CE, Smith MA, Clark MB, Ru K, Mercer TR, Thompson ER, Lakhani
SR, et al: SNORD-host RNA Zfas1 is a regulator of mammary
development and a potential marker for breast cancer. RNA.
17:878–891. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang JJ, Chen JT, Yao KH, Hua L, Wang CY
and Hu JH: Up-regulated expression of long non-coding RNA ZFAS1
associates with aggressive tumor progression and poor prognosis in
gastric cancer patients. Int J Clin Exp Pathol. 9:2059–2063.
2016.
|
